We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$826M
AUM Growth
Cap. Flow
+$577M
Cap. Flow %
69.85%
Top 10 Hldgs %
23.05%
Holding
4,682
New
4,618
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$33M
2
AAPL icon
Apple
AAPL
+$32.5M
3
BKNG icon
Booking.com
BKNG
+$28.7M
4
AMZN icon
Amazon
AMZN
+$25.7M
5
BIDU icon
Baidu
BIDU
+$16.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.8%
2 Technology 11.13%
3 Healthcare 8.34%
4 Energy 5.42%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMED
2776
PUT
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$7K ﹤0.01%
+33
New +$676
NADL
2777
PUT
DELISTED
North Atlantic Drilling Ltd
NADL
$7K ﹤0.01%
+6
New +$239
OIL
2778
PUT
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$7K ﹤0.01%
+40
New +$710
AB icon
2779
PUT
AllianceBernstein
AB
$3.47B
$6K ﹤0.01%
+40
New +$1.02K
EFOR
2780
Everforth Inc
EFOR
$845M
$6K ﹤0.01%
+193
New +$5.8K
ATI icon
2781
ATI
ATI
$27B
$6K ﹤0.01%
+178
New +$5.88K
AWI icon
2782
CALL
Armstrong World Industries
AWI
$6.86B
$6K ﹤0.01%
+15
New +$743
AXDX
2783
CALL
DELISTED
Accelerate Diagnostics
AXDX
$6K ﹤0.01%
+3
New +$642
BAH icon
2784
Booz Allen Hamilton
BAH
$8.7B
$6K ﹤0.01%
+236
New +$6.13K
CLH icon
2785
PUT
Clean Harbors
CLH
$16.1B
$6K ﹤0.01%
+26
New +$1.27K
CLX icon
2786
PUT
Clorox
CLX
$11.6B
$6K ﹤0.01%
+101
New +$10.1K
CNI icon
2787
CALL
Canadian National Railway
CNI
$78.3B
$6K ﹤0.01%
+24
New +$1.64K
CNP icon
2788
PUT
CenterPoint Energy
CNP
$29.1B
$6K ﹤0.01%
+72
New +$1.72K
COHU icon
2789
PUT
Cohu
COHU
$2.39B
$6K ﹤0.01%
+34
New +$386
CPRT icon
2790
CALL
Copart
CPRT
$25.9B
$6K ﹤0.01%
+568
New +$2.44K
CROX icon
2791
Crocs
CROX
$6.69B
$6K ﹤0.01%
+459
New +$5.68K
CVE icon
2792
CALL
Cenovus Energy
CVE
$54.6B
$6K ﹤0.01%
+13
New +$299
EPV icon
2793
ProShares UltraShort FTSE Europe
EPV
$11.6M
$6K ﹤0.01%
+18
New +$5.62K
FF icon
2794
Future Fuel
FF
$204M
$6K ﹤0.01%
+468
New +$5.76K
FUN icon
2795
CALL
Cedar Fair
FUN
$1.78B
$6K ﹤0.01%
+15
New +$699
GFI icon
2796
PUT
Gold Fields
GFI
$29.2B
$6K ﹤0.01%
+19
New +$76
GIL icon
2797
CALL
Gildan
GIL
$9.25B
$6K ﹤0.01%
+30
New +$854
GREK
2798
Global X MSCI Greece ETF
GREK
$288M
$6K ﹤0.01%
+154
New +$7.42K
GTLS
2799
CALL
DELISTED
Chart Industries
GTLS
$6K ﹤0.01%
+59
New +$2.46K
HLF icon
2800
Herbalife
HLF
$1.23B
$6K ﹤0.01%
+300
New +$6.42K

Similar funds

Simplex Trading's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Simplex Trading, which disclosed 4,682 positions worth $826M. Its ten largest holdings account for 23% of the portfolio.

Its largest position is Gilead Sciences: 319,426 shares worth $30.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, followed by Technology and Healthcare.

  • Simplex Trading's largest Q4 2014 buy was Gilead Sciences: 319,426 shares worth $30.1M.
  • Simplex Trading's ten largest holdings make up 23% of its $826M portfolio in Q4 2014.
  • Simplex Trading disclosed 4,682 positions in Q4 2014, its first 13F filing on record.

Based on Simplex Trading's 13F filing for Q4 2014, filed 4 Mar 2015.